Sanofi is in discussions with the French government to address concerns officials raised about a potential sale of a controlling stake in the company’s consumer health business, Opella, to private-equity firm Clayton Dubilier & Rice.
Sanofi is in discussions with the French government to address concerns officials raised about a potential sale of a controlling stake in the company’s consumer health business, Opella, to private-equity firm Clayton Dubilier & Rice.